Written by Prabha Raghavan | New Delhi | Updated: November 20, 2020 7:08:08 am The candidate, who is being manufactured by SII under an agreement with Oxford-AstraZeneca, is the pioneer in India’s own race to find a vaccine to defeat the novel coronavirus. (Photo of Fie) Serum Institute of India …
Read More »
By James Paton The University of Oxford confirmed that the Covid-19 vaccine it is developing with AstraZeneca Plc produced strong immune responses in older adults in an initial study, and key findings are expected from the final phase of trials in the coming weeks. The results, published Thursday in the …
Read More »
Gilead’s Remdesivir drug is not recommended for hospitalized Covid-19 patients, regardless of how ill they are, as there is no evidence that it improves survival or reduces the need for ventilation, a panel from the World Organization of health. “The … panel found a lack of evidence that Remdesivir improved …
Read More »
Noting that it is natural to prioritize the Covid-19 vaccine distribution process, Health Minister Harsh Vardhan said on Thursday that health workers and people over 65 will receive the coronavirus vaccine as a priority. Addressing FICCI FLO’s national webinar on ‘The Shifting Paradigm of Healthcare During and After Covid’, Vardhan …
Read More »
It was in 2011, shortly after assuming the role of CEO of the Serum Institute of India (SII), that Adar Poonawalla set out to double the capacity of what is now the world’s largest vaccine manufacturer by volume. Initially motivated by economies of scale, Poonawalla, whose father Cyrus founded the …
Read More »
Results from an early-phase randomized clinical trial of Chinese vaccine candidate Covid-19 CoronaVac show that the formulation appears safe and induces an antibody response in volunteers aged 18 to 59 years. The results, published in The Lancet, add to the number of candidate vaccines tested that have been found safe. …
Read More »
Noida / Ghaziabad: Eleven people who entered Noida and Ghaziabad from Delhi tested positive during random tests for coronavirus disease (Covid-19) by officials from the two cities on Wednesday. Despite the fact that the Gautam Budh Nagar district administration had announced on Tuesday that travelers from Delhi will undergo random …
Read More »
CHANDIGARH: Haryana’s Health Minister Anil Vij, who had volunteered to be the first volunteer in phase three trials of Covaxin, a possible vaccine against Covid-19, will receive the dose on Friday. The 67-year-old Bharatiya Janata Party leader said he will be given the test dose of the indigenous vaccine at …
Read More »
The world’s first Covid-19 home test was approved (for emergency use) by the US Food and Drug Administration on Tuesday. Performed by Lucira Health, this is a molecular test that is relatively inexpensive (according to the company’s website, it will cost less than $ 50) and quick (30 minutes). The …
Read More »
As the COVID-19 The case count in India rose to more than 90 lakh on Thursday, the executive director and owner of the Pune-based Serum Institute of India, Adar Poonawalla, said the country could look forward to a vaccine against the novel coronavirus by the end of the year or …
Read More »